References
1. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol . 1992;19(3):424-430.
2. Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still’s disease. J Autoimmun . 2018;93:24-36.
3. Zhu G, Liu G, Liu Y, Xie Q, Shi G. Liver abnormalities in adult onset Still’s disease: a retrospective study of 77 Chinese patients. J Clin Rheumatol . 2009;15(6):284-288.
4. Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P. Adult-onset Still’s disease. Autoimmun Rev . 2014;13(7):708-722.
5. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases. Hepatology . 2020;72(2):671-722.
6. Xia LX, Xiao T. An unusual case of autoimmune hepatitis in a patient with adult-onset Still’s disease. Clin Rheumatol . 2010;29(1):95-97.
7. Liu LL, Feng ML, Wang LN, Li XL, Yao L. A case report of successful treatment with plasma exchange for adult-onset Still’s disease with autoimmune hepatitis. J Clin Apher . 2010;25(2):74-76.
8. Fujii K, Rokutanda R, Osugi Y, Koyama Y, Ota T. Adult-onset Still’s disease complicated by autoimmune hepatitis: successful treatment with infliximab. Intern Med . 2012;51(9):1125-1128.
9. Kojima H, Uemura M, Sakurai S, et al. Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol . 2002;37(8):617-625.
10. Kakar S, Kamath PS, Burgart LJ. Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment?Arch Pathol Lab Med . 2004;128(8):901-904.
11. Sari A, Tunakan M, Ozmen M, Turkkan E. Ground-glass-like hepatocellular inclusions in the course of adult-onset Still’s disease.Mod Rheumatol . 2010;20(1):90-92.
12. Czaja AJ. Diagnosis and management of autoimmune hepatitis: current status and future directions. Gut Liver . 2016;10(2):177-203.
13. Miao Q, Bian Z, Tang R, et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis.Clin Rev Allergy Immunol . 2015;48(2-3):226-235.
14. Pongpaibul A, Venick RS, McDiarmid SV, Lassman CR. Histopathology of de novo autoimmune hepatitis. Liver Transpl . 2012;18(7):811-818.
15. Drepper M, Rubbia-Brandt L, Spahr L. Tocilizumab-induced acute liver injury in adult onset Still’s disease. Case Reports Hepatol . 2013;2013:964828.
16. Efe C, Purnak T, Ozaslan E, Wahlin S. Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor α agents.Hepatology . 2010;52(6):2246-2247.
17. Taubert R, Hardtke-Wolenski M, Noyan F, et al. Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. PLOS ONE . 2017;12(6):e0179074.
18. Fujii T, Nojima T, Yasuoka H, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still’s disease. Association with chronic articular disease. Rheumatology (Oxford) . 2001;40(12):1398-1404.
19. Abe K, Takahashi A, Imaizumi H, et al. Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis. Springerplus . 2016;5(1):777.
20. van Gerven NMF, Verwer BJ, Witte BI, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol . 2013;58(1):141-147.